MDEV ETF — First Trust Exchange-Traded Fund VI - First Trust Indxx Medical Devices ETF

First Trust Exchange-Traded Fund VI - First Trust Indxx Medical Devices ETF (MDEV)

Updated October 16, 2026.

MDEV is an ETF. its trailing-12-month yield is 0.10%, its expense ratio is 0.70%. Total return is -15.4% over the past 5.3 years, 109.1 points behind SPY at 93.7%.

First Trust Indxx Medical Devices ETF is an equity fund that tracks an index of companies in the medical equipment industry, investing at least 80% of its assets in index constituent securities. The fund does not currently distribute to shareholders, though it has made special distributions in the past that may not recur regularly. It carries an expense ratio of 0.70% and holds a modest asset base.

MDEV performance versus SPY

Price and return data through 2026-10-16.

Total return is -15.4% over the past 5.3 years, 109.1 points behind SPY at 93.7%. Over the past year its total return — price change plus distributions reinvested — is 4.8%. Its deepest 1-year drawdown was 18.1%.

MDEV key facts

Issuer

First Trust

Asset type

ETF

Asset class

Equity

Inception date

06/22/2021

Expense ratio

0.70%

Trailing yield

0.10%

Last close

$21.33 (as of 2026-10-16)

AUM

$3,147,029

Average volume

1163.0

Dividend

$0.022

Ex-dividend date

06/25/2026

Payment date

06/30/2026

Beta

0.86

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (0.10%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: First Trust or company page; prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

MDEV risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 18.1%.

Who may consider MDEV — and who may not

It is a weaker fit for investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on MDEV

• All tickers starting with M

Frequently asked questions

More securities from First Trust.